Articles:
Publications:

2 hours ago

Interview: Clinical trial on Bundibugyo strain an important step in Ebola response, Africa CDC chief says

Interview: Clinical trial on Bundibugyo strain an important step in Ebola response, Africa CDC chief says

ADDIS ABABA, July 7 (Xinhua) -- Director General of the Africa Centers for Disease Control and Prevention (Africa CDC) Jean Kaseya has hailed the official launch of a clinical trial of therapeutics on the Bundibugyo Ebola strain as an "important... Read more.

More from Xinhua News Agency

Xinhua News Agency 4 hours ago
Turn on Transparency.
Sports Beats of 24 Solar Terms: Lesser Heat
Owner: Chinese Government through The State Council of the People's Republic of China More info
Xinhua News Agency 4 hours ago
Turn on Transparency.
Rescue underway as landslide in northwest China's Gansu kills 5
Owner: Chinese Government through The State Council of the People's Republic of China More info
Xinhua News Agency 3 hours ago
Turn on Transparency.
China unveils measures to build Shanghai into global reinsurance hub
Owner: Chinese Government through The State Council of the People's Republic of China More info
More

Keep exploring Perspectify!

Create a free account and bring
more transparency to your news.

Already have an account? Log in.

Today's Media Watch

Your daily guide to the stories shaping media, journalism, and public trust.

6 hours ago
AFP Journalists in Turkey Go on Strike Over Pay as Union Cites Inflation Gap
Neutral | Owner: International Journalists Association
6 hours ago
Kuwait Steps up Battle Against AI-Driven Misinformation
Center-left | Owner: Ahmed Al-Jarallah
6 hours ago
Journalists Turn to Courts to Combat Censorship Fears After Senate Abandons Modern Press Freedom Framework in the Dominican Republic
Neutral | Owner: Dolores Vicioso

Learn About Our Fact-Based Transparency System

Our proprietary bias labels help you understand each outlet’s political orientation, editorial independence, and credibility based on factors like ownership, funding, affiliations, content, and media freedom. Learn more in the Perspectify FAQ.

Learn more